Charles River Laboratories International, Inc.
CRL- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001100682
In the last 90 days, Charles River Laboratories International, Inc. insiders filed 1 open-market purchase and 9 sales; 569 institutions reported holding it in 13F filings for Q2 2026, worth $12.9B in total; Harris Associates (Oakmark) is the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Charles River Laboratories International, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 708 | 8 | 644 | −56 |
| Shares | 47.2M | 13.0K | 47.6M | +427.2K (+0.9%) |
| Value | $17.8B | $4.89M | $13.5B | −$4.25B (−24.0%) |
8 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (60)
Institutions that held Charles River Laboratories International, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (116)
Institutions that held Charles River Laboratories International, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
Showing the largest 100 of 116 by value.
Not filed for Q1 2022 yet (8)
Institutions that held Charles River Laboratories International, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Andra AP-fonden | 4,700 | $1.77M |
| Tdam USA Inc. | 3,372 | $1.27M |
| Metatron Capital SICAV plc | 2,600 | $979.6K |
| NEXT Financial Group, Inc | 1,977 | $745.0K |
| Carroll Financial Associates, Inc. | 192 | $72.0K |
| Reilly Financial Advisors, LLC | 47 | $18.0K |
| Bell Investment Advisors, Inc | 43 | $16.0K |
| Harbour Investments, Inc. | 36 | $14.0K |